Dr. Salman Azhar, MD

Dr. Azhar practices at Lenox Hill Hospital in New York, New York.

Dr. Azhar's NPI, 1952460479, was assigned on December 8, 2006. Dr. Azhar graduated from VCU School of Medicine in 1993. Dr. Azhar holds New York license 205784.

Dr. Azhar's primary practice is Lenox Hill Hospital, at 130 E 77th St, New York, NY 10075 in New York County. The practice phone is (212) 434-3000.

Dr. Azhar's primary practice is Lenox Hill Hospital in New York, New York. Dr. Azhar is also affiliated with Lenox Hill Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Azhar to 3 more hospitals, 3 medical groups, 2 group practices and clinics and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azhar practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Azhar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Azhar is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Azhar is licensed in New York.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, fibromyalgia and chronic pain, headaches, hypersomnia and lower back pain among the conditions Dr. Azhar treats.

CMS data shows 711 Medicare services from Dr. Azhar across 12 procedure codes in 2024, for 345 Medicare patients. Medicare paid $88,653 for them.

CMS counts 345 Medicare patients who saw Dr. Azhar in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Azhar's median patient age at 74, with 59% women.

In 2024, Dr. Azhar wrote 385 Medicare Part D claims for 99 patients. 82% of them were for generic drugs. CMS names the drug for 256 of them, across 14 drugs with 11 or more claims each, at $629,754 in total drug cost. In 2023, CMS named 271 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Azhar for performance year 2024, reported through an alternative payment model (APM). Dr. Azhar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Azhar as offering telehealth.

Dmand AI links 72 papers to Dr. Azhar, published from 2003 to 2023. 2014 was the busiest year, with 8. The most frequent topics are Steroids, Mice, Inbred C57BL and Cell Line. Dr. Azhar has published most often in J Lipid Res. Dr. Azhar's most frequent co-authors are Fredric B. Kraemer, MD, Shailja Patel, MD and Amar Singh, MD.

Dmand AI links Dr. Azhar to 1 clinical trial. Conditions studied include Ischemic Stroke and Stroke.

CMS Open Payments shows 111 general payments to Dr. Azhar from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Medtronic, Inc. paid the most, $32,560.

Dmand AI lists 2 awards for Dr. Azhar, most recently Top Doctors: New York Metro Area in 2017. Dr. Azhar serves on New York DOH Stroke Advisory Group.

Dr. Azhar graduated from VCU School of Medicine in 1993. Dr. Azhar is a member of AAN, AHA and AMA.

Dr. Azhar is in network with 18 carriers, including Aetna, Elevance and MVP Health Care. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.